Julien Gautier

Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma

Marie Paule Sablin, S. Négrier, Alain Ravaud et al. · The Journal of Urology · 2009 · 154 citations

High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR

Souad Assaad, Virginie Avrillon, Marie-Line Fournier et al. · European Journal of Cancer · 2020 · 124 citations · Full text

Viral Diagnostics, Medicine, Covid-19 Pandemic +8

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial

Olivier Mir, Claire Cropet, Maud Toulmonde et al. · The Lancet Oncology · 2016 · 120 citations

Open-label Phase 2, Gastrointestinal Oncology, Medicine +7

Sequential use of sorafenib and sunitinib in renal cancer: Retrospective analysis in 90 patients

Marie‐Paule Sablin, Linda Bouaita, Corinne Balleyguier et al. · Journal of Clinical Oncology · 2007 · 75 citations

Cross Resistance, Urology, Sequential Use +13

<scp>PALLIA</scp>‐10, a screening tool to identify patients needing palliative care referral in comprehensive cancer centers: A prospective multicentric study (<scp>PREPA</scp>‐10)

Yann Molin, Caroline Gallay, Julien Gautier et al. · Cancer Medicine · 2019 · 53 citations · Full text